Product Information

TOPIRAMATE ER 200 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $17.4129 per EA under NDC 68382035806. Its NADAC has been published 149 times since Jan 10, 2024.

FDA first approved this application on Nov 24, 2017. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 200 MG CAPSULE

Topiramate
$17.4129per EA

Strength

200 mg/1

NDC

68382035806

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA207382

FDA Approved

11/24/2017

TE Code

AB1

On Market Since

11/13/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 200 MG CAPSULE has been published 149 times since Jan 10, 2024, and over the history we have for it it has declined 49.9%. The table below summarizes its recorded NADAC range and movement.

Current price$17.4129 per EA
All-time high$34.7626 (Jan 10, 2024)
All-time low$17.4129 (Oct 21, 2026)
52-week high$25.6532
52-week low$17.4129
Median price$24.8153
Average price$24.9416
Largest weekly change-20.0% (Mar 20, 2024)
Weeks tracked149
Tracking sinceJan 10, 2024

Price History

1W

0.0%

1M

-14.5%

3M

-26.7%

6M

-23.3%

1Y

-32.2%

3Y

N/A

5Y

N/A

All

-49.9%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 43% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 200 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $17.4129 per EA (NDC 68382035806), effective Nov 11, 2026.

How has the price of TOPIRAMATE ER 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has declined 49.9%. It has been tracked across 149 weekly CMS publications since Jan 10, 2024.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 200 MG CAPSULE?

Since Jan 10, 2024, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has ranged from a low of $17.4129 (Oct 21, 2026) to a high of $34.7626 (Jan 10, 2024), with a median of $24.8153 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 200 MG CAPSULE?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 200 MG SPRINK CAP, is $9.8895 per EA — about 43% below TOPIRAMATE ER 200 MG CAPSULE.

Who manufactures TOPIRAMATE ER 200 MG CAPSULE?

TOPIRAMATE ER 200 MG CAPSULE (NDC 68382035806) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.